9
Views
64
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Cyclic AMP Blocks Cell Growth through Raf-1-Dependent and Raf-1-Independent Mechanisms

, &
Pages 3717-3728 | Received 01 Nov 2001, Accepted 02 Mar 2002, Published online: 27 Mar 2023
 

Abstract

It is widely accepted that cyclic AMP (cAMP) can block cell growth by phosphorylating Raf-1 on serine 43 and inhibiting signaling to extracellular signal-regulated protein kinase. We show that the suppression of Raf-1 by cAMP is considerably more complex than previously reported. When cellular cAMP is elevated, Raf-1 is phosphorylated on three residues (S43, S233, and S259), which work independently to block Raf-1. Both Ras-dependent and Ras-independent processes are disrupted. However, when cAMP-insensitive versions of Raf-1 are expressed in NIH 3T3 cells, their growth is still strongly suppressed when cAMP is elevated. Thus, although Raf-1 appears to be an important cAMP target, other pathways are also targeted by cAMP, providing alternative mechanisms that lead to suppression of cell growth.

We thank A. Chiloeches for helpful comments and for generating pMCEF-mRaf-1. We thank members of the Signal Transduction Laboratory for stimulating discussions and C. Marshall for critical reading of the manuscript. We thank J. Metcalf for peptide synthesis, H. King for DNA sequencing, and J. Cordell for technical expertise.

This work was funded by grants from the Medical Research Council (component grant: G9900391), Cancer Research UK, and The Institute of Cancer Research.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.